Particle.news

Download on the App Store

Majority of US Infants Lack Bifidobacterium, Heightening Allergy Risk

Researchers have launched clinical trials of a Bifidobacterium supplement after longitudinal data revealed widespread deficiencies in this protective microbe among infants

Image
© marishkaSm via Shutterstock

Overview

  • The My Baby Biome study found 76% of US infants had deficient levels of Bifidobacterium and 25% had none detectable.
  • Infants with low or no Bifidobacterium were at least three times more likely to develop allergies, eczema or asthma by age two.
  • Researchers link the microbe’s decline to cesarean deliveries, antibiotic exposure and shifts toward processed diets over fermented foods.
  • The ongoing seven-year study tracks gut microbiomes and health outcomes in more than 400 infants to assess long-term effects.
  • Persephone Biosciences is testing a probiotic formulation containing Bifidobacterium, human milk sugars and vitamin D, with results expected later this year.